World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
96
Citations
49085
World Ranking
1791
National Ranking
987

Overview

Karl Münger is affiliated with Tufts University in the United States and has contributed extensively to research in Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans several subfields, including Epidemiology, Molecular Biology, Cancer Research, Infectious Diseases, and Oncology.

Their primary research topics cover a variety of areas such as:

  • Cervical Cancer and HPV Research
  • Cancer-related molecular mechanisms research
  • Virus-based gene therapy research
  • Viral gastroenteritis research and epidemiology
  • RNA modifications and cancer
  • Immunotherapy and Immune Responses
  • Cancer-related Molecular Pathways

Münger has published research articles in several key scientific journals. The frequent publication venues include:

  • mBio
  • Journal of Virology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Viruses
  • Pathogens

Some of their recent papers are:

  • "The Role of Long Noncoding RNAs in Human Papillomavirus-associated Pathogenesis" (2020, Pathogens)
  • "A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation" (2020, Journal of Virology)
  • "Label-free, High-Resolution Optical Metabolic Imaging of Human Cervical Precancers Reveals Potential for Intraepithelial Neoplasia Diagnosis" (2020, Cell Reports Medicine)
  • "Expression of the Long Noncoding RNA DINO in Human Papillomavirus-Positive Cervical Cancer Cells Reactivates the Dormant TP53 Tumor Suppressor through ATM/CHK2 Signaling" (2020, mBio)
  • "Beta human papillomaviruses and skin cancer" (2020, Nature)

The scientist has collaborated frequently with several co-authors, including:

  • Miranda Grace
  • Elizabeth White
  • Paul F. Lambert
  • Surendra Sharma
  • Felicia Goodrum

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy

    Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham

  • The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

    Nicholas Dyson;Peter M. Howley;Karl Münger;Ed Harlow

  • The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

    K Münger;W C Phelps;V Bubb;P M Howley

  • Vitamin D intake and incidence of multiple sclerosis

    K. L. Munger;S. M. Zhang;E. O’Reilly;M. A. Hernán

  • Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.

    K Münger;B A Werness;N Dyson;W C Phelps

  • Mechanisms of Human Papillomavirus-Induced Oncogenesis

    Karl Münger;Amy Baldwin;Kirsten M. Edwards;Hiroyuki Hayakawa

  • Human papillomavirus immortalization and transformation functions.

    Karl Münger;Peter M Howley

  • The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines

    Martin Scheffner;Karl Münger;Janet C. Byrne;Peter M. Howley

  • The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A

    William C. Phelps;Carole L. Yee;Karl Münger;Peter M. Howley

  • Biological activities and molecular targets of the human papillomavirus E7 oncoprotein

    Karl Münger;John R Basile;Stefan Duensing;Alexandra Eichten

  • TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains

    Jennifer A. Pietenpol;Roland W. Stein;Elizabeth Moran;Peter Yaciuk

  • Human viral oncogenesis: a cancer hallmarks analysis.

    Enrique A. Mesri;Mark A. Feitelson;Karl Munger

  • The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle.

    Stefan Duensing;Lily Y. Lee;Anette Duensing;John Basile

  • The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2

    D. Leanne Jones;Rhoda M. Alani;Karl Münger

  • Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia.

    Jeffrey T. Keating;Aida Cviko;Sabine Riethdorf;Lutz Riethdorf

  • Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins.

    N Dyson;P Guida;K Münger;E Harlow

  • Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins.

    Stefan Duensing;Karl Münger

  • The human papillomavirus E7 oncoprotein.

    Margaret E. McLaughlin-Drubin;Karl Münger

  • Viruses associated with human cancer.

    Margaret E. McLaughlin-Drubin;Karl Munger

  • The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.

    Stefan Duensing;Karl Münger

Frequent Co-Authors

Peter M. Howley
Peter M. Howley Harvard Medical School
Alberto Ascherio
Alberto Ascherio Harvard University
Ed Harlow
Ed Harlow Harvard University
James A. DeCaprio
James A. DeCaprio Harvard University
Jennifer A. Pietenpol
Jennifer A. Pietenpol Vanderbilt University Medical Center
Elliott Kieff
Elliott Kieff Harvard University
Frederick P. Roth
Frederick P. Roth Lunenfeld-Tanenbaum Research Institute
John Quackenbush
John Quackenbush Harvard University
Marc Vidal
Marc Vidal Harvard University
Rameen Beroukhim
Rameen Beroukhim Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Karl Münger

Trending Scientists

Recently Published Articles